NAFLD is silent in the vast majority of people for years. Early symptoms, when present, are nonspecific — fatigue, dull right upper quadrant discomfort, mild nausea — and many people first learn they have it from a routine ALT or abdominal ultrasound. Advanced cirrhosis introduces clear warning signs like jaundice, ascites, and confusion, but those represent failure of earlier detection. Anyone with diabetes or obesity should be screened proactively.
Why NAFLD Hides for So Long
The liver has tremendous reserve capacity. It can be 50 percent or more replaced by fat and still perform its core functions without obvious symptoms. Fibrosis progresses slowly over years to decades, and the liver itself has no pain fibers — discomfort happens only when the capsule (the outer layer) is stretched by hepatomegaly. This is why NAFLD can advance silently to cirrhosis before patients notice.
Stage-by-Stage Symptom Map
| Stage | Typical Symptoms |
|---|---|
| Simple steatosis (NAFL) | Usually none; sometimes mild fatigue or elevated ALT on labs |
| NASH (F0 to F2 fibrosis) | Fatigue, right upper quadrant discomfort, mild nausea |
| Bridging fibrosis (F3) | Same as NASH; may begin to see low platelets, mild ascites |
| Compensated cirrhosis (F4) | Fatigue, easy bruising, palmar erythema, spider angiomas, mild edema |
| Decompensated cirrhosis | Jaundice, ascites, variceal bleeding, hepatic encephalopathy |
Common Early Symptoms
- Persistent fatigue — the single most commonly reported symptom
- Right upper quadrant discomfort or fullness — often described as dull, achy, or “tight”
- Mild nausea — especially after large or fatty meals
- Poor concentration or “brain fog” — sometimes related to sleep disruption
- Reduced exercise tolerance
- Vague abdominal discomfort
None of these symptoms is specific to NAFLD, which is one reason screening — rather than waiting for symptoms — is the modern approach.
Lab Findings That Point to NAFLD
| Lab | Typical NAFLD Pattern |
|---|---|
| ALT | Often mildly elevated (typically 40 to 200 U/L) |
| AST | Often elevated but lower than ALT (AST/ALT ratio < 1) |
| GGT | Often mildly elevated |
| Alkaline phosphatase | Usually normal or mildly elevated |
| Platelets | Normal early; falls with advancing fibrosis |
| Albumin | Normal early; falls in cirrhosis |
| Bilirubin | Normal until late |
| INR / PT | Normal until advanced |
| Triglycerides | Often elevated |
An AST/ALT ratio greater than 1 in someone with established NAFLD often signals advancing fibrosis and warrants additional workup.
Signs and Symptoms of Advanced Disease
- Jaundice — yellow discoloration of skin and eyes (elevated bilirubin)
- Ascites — abdominal swelling from fluid accumulation
- Peripheral edema — swollen ankles and legs
- Easy bruising or bleeding — from low platelets and clotting factor deficiency
- Palmar erythema — red coloration of palms
- Spider angiomas — small dilated blood vessels, usually on the upper torso
- Hepatic encephalopathy — confusion, day-night reversal, slowed thinking
- Gynecomastia in men — breast tissue growth from altered hormone metabolism
- Variceal bleeding — vomiting blood or black stool from esophageal varices
- Unintentional weight loss and muscle wasting
Symptoms Often Confused with NAFLD
| Symptom | Other Causes to Consider |
|---|---|
| Right upper quadrant pain | Gallstones, cholecystitis, hepatitis, peptic ulcer, costochondritis |
| Fatigue | Anemia, hypothyroidism, sleep apnea, depression, vitamin D deficiency |
| Elevated ALT | Viral hepatitis, alcohol, medications (statins, acetaminophen), muscle injury, celiac disease |
| Abdominal fullness | Gas, IBS, constipation, ascites, intra-abdominal mass |
Who Should Be Screened — Even Without Symptoms
ADA, AASLD, and AACE guidelines now recommend FIB-4 screening in:
- All adults with type 2 diabetes
- All adults with prediabetes plus one cardiometabolic risk factor
- Adults with persistently elevated liver enzymes
- Adults with obesity (BMI ≥ 30) or central obesity
- Adults with metabolic syndrome
- People undergoing bariatric surgery
- Family members of patients with advanced NAFLD/NASH cirrhosis
FIB-4 uses age, AST, ALT, and platelet count and can be calculated from a routine lab panel. See our overview on A1C levels for context on glucose targets and our complications hub for the broader picture of why this matters.
Red Flags — Seek Care Promptly
- New jaundice (yellow eyes or skin)
- Rapidly increasing abdominal girth or leg swelling
- Vomiting blood or black tarry stool
- New confusion or unusual sleepiness
- Severe right upper quadrant pain
- Unexplained weight loss greater than 5 percent in 6 months
- Easy bruising or bleeding
These suggest decompensated cirrhosis or another serious liver condition and warrant urgent evaluation.
What Happens When Symptoms Prompt a Workup
- Detailed history including alcohol, medications, supplements, family history
- Lab panel — ALT, AST, GGT, alkaline phosphatase, bilirubin, albumin, INR, platelet count, lipids, A1C, ferritin, viral hepatitis serologies, autoimmune panel
- FIB-4 calculation
- Abdominal ultrasound
- FibroScan or MR elastography if FIB-4 elevated
- Referral to hepatology for indeterminate or elevated fibrosis assessment
- Biopsy in selected cases
How Symptoms Change with Treatment
With successful weight loss and dietary change, many patients report improved energy and reduced abdominal discomfort within weeks to a few months. Liver enzymes typically normalize before imaging changes. Persistent fatigue despite improving labs may signal coexisting sleep apnea, depression, or unrelated causes and should be investigated separately.
Related Reading
For background on the condition, see NAFLD and diabetes and NASH and diabetes. For diet-driven management, see the fatty liver and diabetes diet. The NIDDK overview at NIDDK is patient-friendly.
The Bottom Line
NAFLD is symptom-poor for most of its course. When symptoms exist they are vague — fatigue, dull right upper quadrant discomfort, mild nausea — and rarely point clearly to the liver. Advanced symptoms like jaundice, ascites, and confusion arrive too late for many of the best interventions. Because of this, screening with FIB-4 in everyone with type 2 diabetes or prediabetes plus risk factors is now standard. Anyone with new red-flag symptoms should seek care promptly; anyone with diabetes should ask their clinician about fibrosis screening regardless of how they feel.
